Publicaciones en colaboración con investigadores/as de National and Kapodistrian University of Athens (5)

2022

  1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

    The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45

2016

  1. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

    European Journal of Heart Failure, Vol. 18, Núm. 6, pp. 613-625

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

2008

  1. Levosimendan in the treatment of AHF: Lessons from surveys and clinical trials

    European Journal of Heart Failure, Supplement, Vol. 7, Núm. SUPPL. 2, pp. 228-233

  2. Levosimendan: A decade of experience in Europe built on years of evidence

    European Journal of Heart Failure, Supplement, Vol. 7, Núm. SUPPL. 2, pp. 234-243